We are developing a new generation of targeted immunotherapies that  attack solid tumors, and then teach the immune system to hunt down cancer cells elsewhere in the body.
Science
Discover the future of biotherapeutics with Calidi. Pioneering innovative solutions for solid tumors.
Company Overview
Take a glimpse into Calidi's headquarters, based in San Diego, California, including members of our exceptional team. This video also highlights the latest updates on the company's Clinical Trials and path to becoming a publicly traded company.
Investors
Join us on our journey towards creating a world free from the threat of cancer.
Latest News
Press Release
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer
November 18, 2024
Discover More
Discover More
Press Release
Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock
November 15, 2024
Discover More
Discover More
Press Release
Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock
November 14, 2024
Discover More
Discover More